Home » Plavix Patent Protected by Supreme Court Denial
Plavix Patent Protected by Supreme Court Denial
The Supreme Court denial of Apotex’s petition challenging a patent on Sanofi-Aventis and Bristol-Myers Squibb’s blood-thinner drug Plavix
protects a patent on the drug that Apotex had contended was not strong enough to maintain validity. The court’s decision not to review the case ends
an eight-year legal battle over the blockbuster drug that began when Apotex applied for FDA approval to market a generic Plavix (clopidogrel bisulfate)
in November 2001.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May